Literature DB >> 7617876

Musculoskeletal MR imaging at 4 T and at 1.5 T: comparison of relaxation times and image contrast.

S H Duewell1, T L Ceckler, K Ong, H Wen, F A Jaffer, S A Chesnick, R S Balaban.   

Abstract

PURPOSE: To evaluate the relaxation time-based contrast between the main tissues of the musculoskeletal system as measured in the human knee with magnetic resonance imaging at 4 T and 1.5 T.
MATERIALS AND METHODS: Five volunteers underwent 4-T and 1.5-T imaging. Inversion-recovery series were used to measure T1 values, and T2 values were measured with a spin-echo sequence.
RESULTS: T1 values increased in all tissues with 4-T imaging. Values increased in muscle from 1 to 1.8 seconds, in fat from 0.3 to 0.4 seconds, and in cartilage from 0.8 to 1.5 seconds. T2 values were 10%-20% shorter in all tissues at 4 T.
CONCLUSION: Advantages of 4-T imaging compared with 1.5-T imaging include a higher signal-to-noise ratio and an improved signal difference-to-noise ratio. However, any improvement in signal-to-noise ratio at high field strengths can partially be reduced by the increase in the T1 value. The slightly shorter T2 values at 4 T do not affect image contrast.

Entities:  

Mesh:

Year:  1995        PMID: 7617876     DOI: 10.1148/radiology.196.2.7617876

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

Review 1.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

2.  Is the body-coil at 3 Tesla feasible for the MRI evaluation of the painful knee? A comparative study.

Authors:  G Lutterbey; K Behrends; M V Falkenhausen; M P Wattjes; N Morakkabati; J Gieseke; H Schild
Journal:  Eur Radiol       Date:  2006-04-08       Impact factor: 5.315

Review 3.  Muskuloskeletal MR imaging at 3.0 T: current status and future perspectives.

Authors:  Nicolae Bolog; Daniel Nanz; Dominik Weishaupt
Journal:  Eur Radiol       Date:  2006-03-16       Impact factor: 5.315

4.  Intramyocellular lipid quantification: comparison between 3.0- and 1.5-T (1)H-MRS.

Authors:  Martin Torriani; Bijoy J Thomas; Miriam A Bredella; Hugue Ouellette
Journal:  Magn Reson Imaging       Date:  2007-01-18       Impact factor: 2.546

5.  The intrinsic signal-to-noise ratio in human cardiac imaging at 1.5, 3, and 4 T.

Authors:  H Wen; T J Denison; R W Singerman; R S Balaban
Journal:  J Magn Reson       Date:  1997-03       Impact factor: 2.229

6.  A heterogeneous human tissue mimicking phantom for RF heating and MRI thermal monitoring verification.

Authors:  Yu Yuan; Cory Wyatt; Paolo Maccarini; Paul Stauffer; Oana Craciunescu; James Macfall; Mark Dewhirst; Shiva K Das
Journal:  Phys Med Biol       Date:  2012-03-20       Impact factor: 3.609

7.  3-T MRI mapping is a valid in vivo method of quantitatively evaluating the anterior cruciate ligament: rater reliability and comparison across age.

Authors:  Adam W Anz; Jos Edison; Thomas S Denney; Eric A Branch; Christopher R Walz; Kenny V Brock; Michael D Goodlett
Journal:  Skeletal Radiol       Date:  2019-09-03       Impact factor: 2.199

8.  Influence of foot orientation on the appearance and quantification of 1H magnetic resonance muscle spectra obtained from the soleus and the vastus lateralis.

Authors:  Małgorzata Marjańska; Lynn E Eberly; Gregor Adriany; Sarah N Verdoliva; Michael Garwood; Lisa Chow
Journal:  Magn Reson Med       Date:  2012-02-01       Impact factor: 4.668

9.  Radiofrequency (RF) coil impacts the value and reproducibility of cartilage spin-spin (T2) relaxation time measurements.

Authors:  B J Dardzinski; E Schneider
Journal:  Osteoarthritis Cartilage       Date:  2013-01-31       Impact factor: 6.576

Review 10.  Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system.

Authors:  Filippo Del Grande; Francesco Santini; Daniel A Herzka; Michael R Aro; Cooper W Dean; Garry E Gold; John A Carrino
Journal:  Radiographics       Date:  2014 Jan-Feb       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.